Hereby, BTK is essential for constitutively active pathways implicated in CLL cell survival, including AKT, ERK and NF-кB, both in patient cells and mouse models [133, 141–143]. The gene discussed is MAPK1; the disease is B-cell chronic lymphocytic leukemia.